Brief: Galecto Reports Q3 Operating And Financial Results
04/11/2021 22:35
Nov 4 (Reuters) - Galecto Inc GLTO.O :
* GALECTO REPORTS THIRD QUARTER OPERATING AND FINANCIAL
RESULTS
* Q3 LOSS PER SHARE $0.50
Source text for Eikon: ID:nGNX2PwwQc
Further company coverage: GLTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Damora Therapeutics
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. RESEARCH ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics
U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology
Brief: Damora Therapeutics Reports First Quarter 2026 Financial Results
Brief: Damora Therapeutics: Lori Firmani To Cease Serving As CFO Effective May 1, 2026 - SEC Filing